39 related articles for article (PubMed ID: 358461)
21. [Mediators of the immune response and inflammation].
Dayer JM
Ther Umsch; 1986 Feb; 43(2):94-102. PubMed ID: 2421430
[No Abstract] [Full Text] [Related]
22. Mediators of immunity: lymphokines and monokines.
Rocklin RE; Bendtzen K; Greineder D
Adv Immunol; 1980; 29():55-136. PubMed ID: 6158261
[No Abstract] [Full Text] [Related]
23. Mechanisms of natural cell-mediated resistance in human solid tumors.
Allavena P; Merendino A; Di Bello M; Pirelli A; Rossini S; Mantovani A
Biochim Biophys Acta; 1986 Dec; 865(3):281-8. PubMed ID: 2431716
[No Abstract] [Full Text] [Related]
24. Properties and mechanism of action of lymphokines (LK): current state of studies of mediators of cellular immunity. A review.
Jirillo E; Fumarola D
Ann Sclavo; 1979; 21(5):573-620. PubMed ID: 399169
[No Abstract] [Full Text] [Related]
25. Soluble factors produced by lymphocytes.
Valentine FT
Ann N Y Acad Sci; 1974; 221():317-23. PubMed ID: 4594752
[No Abstract] [Full Text] [Related]
26. Tumor immunology and interferon.
Feinerman B
South Med J; 1978 Nov; 71(11):1409-11. PubMed ID: 362539
[TBL] [Abstract][Full Text] [Related]
27. Mediators of cellular immune reactions.
Hanson JM; Rumjanek VM; Morley J
Pharmacol Ther; 1982; 17(2):165-98. PubMed ID: 6184737
[No Abstract] [Full Text] [Related]
28. Human nonspecific suppressive lymphokines.
Halpern MT
J Clin Immunol; 1991 Jan; 11(1):1-12. PubMed ID: 2022719
[TBL] [Abstract][Full Text] [Related]
29. The role of lymphocyte (cell-mediated) immunity in ocular disease. The fifth Frederick H. Verhoeff lecture.
Leopold IH
Am J Ophthalmol; 1973 Nov; 76(5):619-31. PubMed ID: 4594070
[No Abstract] [Full Text] [Related]
30. Interferons, a group of multiple lymphokines.
Kirchner H
Springer Semin Immunopathol; 1984; 7(4):347-74. PubMed ID: 6084313
[No Abstract] [Full Text] [Related]
31. [General considerations on the interferon system].
Pugliese A
G Batteriol Virol Immunol; 1979; 72(1-6):78-114. PubMed ID: 95450
[TBL] [Abstract][Full Text] [Related]
32. Biological properties of lymphokines.
Bendtzen K
Allergy; 1978 Jun; 33(3):105-19. PubMed ID: 360872
[No Abstract] [Full Text] [Related]
33. The molecular regulation of lymphocyte apoptosis.
Lenardo MJ
Semin Immunol; 1997 Feb; 9(1):1-5. PubMed ID: 9106302
[No Abstract] [Full Text] [Related]
34. Lymphokines. Progress and promise.
Horohov DW; Siegel JP
Drugs; 1987 Apr; 33(4):289-95. PubMed ID: 3297615
[No Abstract] [Full Text] [Related]
35. Effect of interferon and lymphokines on lymphocytes.
Gifford GE; Tobey M
Tex Rep Biol Med; 1977; 35():375-80. PubMed ID: 358461
[TBL] [Abstract][Full Text] [Related]
36. [Effect of interferon on immunological reactivity (a review of the literature and our own hypotheses)].
Skurkovich SV; Aleksandrovskaia IM
Probl Gematol Pereliv Krovi; 1973 Mar; 18(3):43-50. PubMed ID: 4588511
[No Abstract] [Full Text] [Related]
37. [Effect of antibiotics on T lymphocyte responses].
Clot J; Eliaou JF
Pathol Biol (Paris); 1987 Dec; 35(10 Pt 2):1435-9. PubMed ID: 3325912
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporine and the immune response: basic aspects.
Hess AD; Colombani PM; Esa AH
Crit Rev Immunol; 1986; 6(2):123-49. PubMed ID: 2942335
[TBL] [Abstract][Full Text] [Related]
39. The cellular and molecular basis of immunological tolerance.
Nossal GJ
Essays Fundam Immunol; 1973; 0(1):28-43. PubMed ID: 4137970
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
